SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors rally behind its successful pivot from smartphone hardware to a dominant position in the physical AI and robotics sectors through its QNX operating system. The community is actively discussing management's upbeat commentary on backlog growth and profitability, fueling optimism that the company is emerging as a critical foundational layer for next-generation automated infrastructure.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing and several peers in the quantum sector are rallying on news that the U.S. government is committing roughly $2 billion in funding via the CHIPS Act, which includes equity stakes in participating companies. The community is actively debating the sustainability of these gains, with many traders discussing potential short squeezes versus concerns that the valuations are detached from current revenue levels and future dilution risks.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is currently trending as investors debate the impact of the company's recent earnings report, which showcased significant year-over-year growth in customer assets and trading volume despite a net loss. The community is actively weighing the potential of a $100 million share buyback and the upcoming removal of day trading restrictions against concerns over high operating expenses and the company's competitive positioning in the fintech sector.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a government-backed funding initiative involving CHIPS Act grants and equity stakes, sparking a massive surge in volume and intense short-squeeze speculation. While bulls are celebrating the sector validation and institutional momentum, skeptics are actively debating the sustainability of the valuation relative to the company's current revenue and cash burn.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is surging on record-breaking volume and institutional demand as the company solidifies its position as a primary AI infrastructure provider through strategic server partnerships and enterprise data center expansion. The community is actively debating the stock's parabolic trajectory and its role as a key AI hardware beneficiary, while closely monitoring institutional buying patterns and management's ongoing corporate and political engagements.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is experiencing significant retail interest and volatility as investors speculate on the potential impact of a looming SpaceX IPO on the broader space infrastructure sector. While bulls are focused on recent partnership expansions and the company's supersonic testing capabilities, the community is deeply divided, with vocal bears highlighting concerns over pending SEC filing delays, cash burn, and looming insider lockup expirations.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing significant community debate and volatility following news that it was excluded from a recent multi-billion dollar government funding initiative, leading some investors to question its long-term leadership position compared to rivals who secured state backing. Despite these concerns, supporters remain highly optimistic, highlighting the company's substantial cash reserves, recent DARPA contracts, and strategic move to vertically integrate through the acquisition of SkyWater Technology as evidence of its continued dominance and resilience in the quantum sector.

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion is experiencing a significant momentum shift as investors react to a breakout above multi-year price levels and heightened interest in the KARNO generator's potential within the AI data center, military, and distributed power sectors. The community is actively debating the company's transition from R&D to commercialization, with sentiment being driven by recent technical validation milestones, institutional activity, and the speculative possibility of near-term military and infrastructure contracts.

Vuzix Corp. is a supplier of Smart-Glasses and Augmented Reality technologies and products for the consumer and enterprise markets. Its products include personal display and wearable computing devices that offer users a portable viewing experience, provide solutions for mobility, wearable displays and augmented reality. The firm also holds 246 patents and patents pending and numerous IP licenses in the Video Eyewear field. It has offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. The company was founded by Paul J. Travers in 1997 and is headquartered in West Henrietta, NY.

Vuzix Corporation

Vuzix is gaining significant momentum as institutional accumulation continues against a backdrop of potential military and enterprise sector catalysts. Community sentiment remains polarized between long-term investors tracking institutional inflows and skeptics citing concerns over insider selling and historical revenue performance.

PicoCELA, Inc. engages in the manufacturing, installation, and services for enterprise wireless mesh solutions. It also offers wireless multi-hop relay devices. The company was founded by Hiroshi Furukawa on August 8, 2008 and is headquartered in Tokyo, Japan.

PicoCELA Inc - ADR

PicoCELA Inc. is experiencing intense retail momentum driven by its status as a low-float Japanese stock, with traders actively tracking its aggressive price volatility and frequent intraday halts. The community remains hyper-focused on its potential for rapid squeezes, though sentiment is split between those chasing the upward momentum and those warning of significant risks associated with the stock's high volatility and potential for quick pullbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -125.56% and -5.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Akebia Therapeutics (AKBA) Expected to Announce Quarterly Earnings on Thursday

Akebia Therapeutics (NASDAQ:AKBA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-akebia-therapeutics-inc-stock...

United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates

United Therapeutics (UTHR) delivered earnings and revenue surprises of -13.58% and -2.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards?

QTTB heads into Q1 earnings with investors eyeing bempikibart updates, as the SIGNAL-AA study progresses with data due in mid-2026.

Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Tops Revenue Estimates

Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +64.71% and +29.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Are Options Traders Betting on a Big Move in Akebia Therapeutics Stock?

Investors need to pay close attention to AKBA stock based on the movements in the options market lately. 

New Strong Sell Stocks for April 28th

EADSY, AKBA and AMTB have been added to the Zacks Rank #5 (Strong Sell) List on April 28, 2026.

Akebia Therapeutics (NASDAQ:AKBA) Shares Cross Below Two Hundred Day Moving Average   - Here's What Happened

Akebia Therapeutics (NASDAQ:AKBA) Stock Crosses Below 200-Day Moving Average - Should You Sell...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six research firms that are covering the stock, Marketbeat.com...

Akebia Therapeutics (NASDAQ:AKBA) Rating Increased to Hold at Zacks Research

Zacks Research upgraded Akebia Therapeutics from a "strong sell" rating to a "hold" rating in a research note on Tuesday...

Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vafseo. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.04	--	--	N/A
Q1 '26	-$0.03	-$0.03	-7.14%	MISSED
Q4 '25	-$0.04	-$0.05	-38.89%	MISSED
Q3 '25	-$0.01	$0.00	100.00%	BEAT
Q2 '25	-$0.02	$0.00	100.00%	BEAT

AKBA
Akebia Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest AKBA News

AKBAAkebia Therapeutics Inc.